LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 116

Search options

  1. Article: Long-Term Safety and Antihypertensive Effects of Renal Denervation: Current Insights.

    Reyes, Klevin Roger L / Rader, Florian

    Integrated blood pressure control

    2023  Volume 16, Page(s) 59–70

    Abstract: Hypertension is the most potent modifiable risk factor for the development of cardiovascular morbidity and mortality worldwide. Nevertheless, blood pressure (BP) control on a broad scale appears to be insurmountable and has even worsened in the US. ... ...

    Abstract Hypertension is the most potent modifiable risk factor for the development of cardiovascular morbidity and mortality worldwide. Nevertheless, blood pressure (BP) control on a broad scale appears to be insurmountable and has even worsened in the US. Barriers to sustained hypertension control are multifactorial and although lack of patient awareness and socioeconomic barriers to healthcare access may play a role, medication non-compliance and therapeutic inertia are major causes. Renal denervation (RDN) is a minimally invasive procedure that has been the subject of interest in clinical trials for more than a decade and although the first sham-controlled trial could not detect group difference between treated and untreated hypertensives, subsequent, better designed sham-controlled trials clearly demonstrated the BP lowering effect of RDN, as well as its safety. While to-date, RDN is not available for routine clinical practice, one major requirement for broad implementation is that the BP lowering effect is durable. Therefore, this review will summarize the available long-term data of the different RDN modalities with respect to both effectiveness and safety.
    Language English
    Publishing date 2023-09-07
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 2520711-8
    ISSN 1178-7104
    ISSN 1178-7104
    DOI 10.2147/IBPC.S392410
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Mavacamten: A First-in-class Oral Modulator of Cardiac Myosin for the Treatment of Symptomatic Hypertrophic Obstructive Cardiomyopathy.

    Reyes, Klevin Roger L / Bilgili, Gizem / Rader, Florian

    Heart international

    2022  Volume 16, Issue 2, Page(s) 91–98

    Abstract: Hypertrophic cardiomyopathy is the most common monogenic cardiovascular disease that is caused by sarcomeric protein gene mutations. A hallmark of the most common form of the disease is outflow obstruction secondary to systolic narrowing of the left ... ...

    Abstract Hypertrophic cardiomyopathy is the most common monogenic cardiovascular disease that is caused by sarcomeric protein gene mutations. A hallmark of the most common form of the disease is outflow obstruction secondary to systolic narrowing of the left ventricular outflow tract from septal hypertrophy, mitral valve abnormalities and, most importantly, hyperdynamic contractility. Recent mechanistic studies have identified excessive myosin adenosine triphosphatase activation and actin-myosin cross-bridging as major underlying causes. These studies have led to the development of mavacamten, a first-in-class myosin adenosine triphosphatase inhibitor and the first specific therapy for hypertrophic obstructive cardiomyopathy. Preclinical and subsequent pivotal clinical studies have demonstrated the efficacy and safety of mavacamten. A remarkable improvement among treated patients in peak oxygen consumption, functional capacity, symptom relief and post-exercise left ventricular outflow tract gradient, along with dramatic reductions in heart failure biomarkers, suggests that this new medication will be transformative for the symptom management of hypertrophic obstructive cardiomyopathy. There is also hope and early evidence that mavacamten may delay or obviate the need for invasive septal reduction therapies. In this article, we review the current evidence for the efficacy and safety of mavacamten and highlight important considerations for its clinical use.
    Language English
    Publishing date 2022-10-05
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2514156-9
    ISSN 2036-2579 ; 2036-2579
    ISSN (online) 2036-2579
    ISSN 2036-2579
    DOI 10.17925/HI.2022.16.2.91
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Response to letter to the editors: Predictors of left atrial appendage thrombus despite NOAC use in nonvalvular atrial fibrillation and flutter.

    Shah, Maulin / Rader, Florian

    International journal of cardiology

    2020  Volume 319, Page(s) 96

    MeSH term(s) Anticoagulants ; Atrial Appendage/diagnostic imaging ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/epidemiology ; Heart Diseases ; Humans ; Thrombosis/diagnostic imaging ; Thrombosis/epidemiology
    Chemical Substances Anticoagulants
    Language English
    Publishing date 2020-07-04
    Publishing country Netherlands
    Document type Letter ; Comment
    ZDB-ID 779519-1
    ISSN 1874-1754 ; 0167-5273
    ISSN (online) 1874-1754
    ISSN 0167-5273
    DOI 10.1016/j.ijcard.2020.06.057
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Sustainability of blood pressure reduction in black barbershops.

    Blyler, Ciantel A / Rader, Florian

    Current opinion in cardiology

    2019  Volume 34, Issue 6, Page(s) 693–699

    Abstract: Purpose of review: The prevalence of hypertension (HTN) among non-Hispanic blacks increased from 41 to 55% with the release of the new 2017 ACC/AHA guidelines - the highest among any racial group. Non-Hispanic black men have less physician interaction ... ...

    Abstract Purpose of review: The prevalence of hypertension (HTN) among non-Hispanic blacks increased from 41 to 55% with the release of the new 2017 ACC/AHA guidelines - the highest among any racial group. Non-Hispanic black men have less physician interaction and lower blood pressure (BP) treatment and control rates when compared with their female counterparts, necessitating community outreach. Here, we review the Los Angeles Barbershop Blood Pressure Study (LABBPS) which demonstrated a community-based approach involving pharmacists, physicians, and barbers could improve BP control rates among black men.
    Recent findings: LABBPS was a cluster-randomized trial that evaluated both the efficacy and sustainability of a pharmacist-led HTN management program in which barbers promoted follow-up with pharmacists who prescribed antihypertensive therapy under collaborative practice agreements with intervention participant's primary care providers. After 6 months researchers observed a 21 mmHg greater fall in SBP among intervention group participants when compared with the control group participants who received 'usual care.' The 6-month extension phase of the study showed that the impressive BP reduction achieved was sustained with less pharmacist contact.
    Summary: Multidisciplinary, community-based approaches to HTN management can be effective and are necessary to tackle the current disparity seen in BP control rates. The model developed in LABBPS represents one such approach.
    MeSH term(s) Adult ; African Americans ; Aged ; Antihypertensive Agents/administration & dosage ; Antihypertensive Agents/therapeutic use ; Barbering ; Blood Pressure Monitoring, Ambulatory/methods ; Community-Institutional Relations ; Humans ; Hypertension/drug therapy ; Hypertension/therapy ; Los Angeles ; Male ; Middle Aged ; Professional-Patient Relations ; Randomized Controlled Trials as Topic
    Chemical Substances Antihypertensive Agents
    Language English
    Publishing date 2019-08-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 645186-x
    ISSN 1531-7080 ; 0268-4705
    ISSN (online) 1531-7080
    ISSN 0268-4705
    DOI 10.1097/HCO.0000000000000674
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Finding Hay in the Haystack.

    Rader, Florian / Blyler, C Adair

    Journal of the American College of Cardiology

    2019  Volume 74, Issue 15, Page(s) 1907–1909

    MeSH term(s) Cell Phone ; Community Health Workers ; Humans ; Hypertension ; Kenya
    Language English
    Publishing date 2019-11-01
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 605507-2
    ISSN 1558-3597 ; 0735-1097
    ISSN (online) 1558-3597
    ISSN 0735-1097
    DOI 10.1016/j.jacc.2019.08.1001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Implication of Right Atrial Pressure Estimated by Echocardiography in Patients with Severe Tricuspid Regurgitation.

    Omori, Taku / Kuwajima, Ken / Rader, Florian / Siegel, Robert J / Shiota, Takahiro

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography

    2023  Volume 36, Issue 11, Page(s) 1170–1177

    Abstract: Background: Little is known about how tightly right atrial pressure (RAP) is associated with prognosis in patients with severe tricuspid regurgitation (TR). The aim of this study was to investigate the association of RAP estimated by echocardiography ( ... ...

    Abstract Background: Little is known about how tightly right atrial pressure (RAP) is associated with prognosis in patients with severe tricuspid regurgitation (TR). The aim of this study was to investigate the association of RAP estimated by echocardiography (RAP-echo) with cardiovascular events in patients with severe TR.
    Methods: Two hundred forty outpatients (median age, 75 years; 130 women) who underwent two-dimensional transthoracic echocardiography and were diagnosed with severe TR were retrospectively studied. According to RAP-echo using the diameter of the inferior vena cava and its response to a sniff, patients were classified into two groups: low or middle and high RAP-echo. Cardiovascular events were defined as cardiovascular death and admission for heart failure.
    Results: During follow-up (median, 428 days; range, 87-1,229 days), 64 patients experienced cardiovascular events. By multivariate analysis, high RAP-echo was independently associated with cardiovascular events (hazard ratio, 2.46; 95% CI, 1.17-5.18). Also, jugular venous distention and leg edema were not independently associated with cardiovascular events.
    Conclusions: The significant and stronger association of RAP-echo with clinical outcome compared with estimates of RAP on physical examination suggests that recognition of high RAP-echo can be a valuable surrogate for the clinical management of severe TR patients.
    MeSH term(s) Humans ; Female ; Aged ; Tricuspid Valve Insufficiency/diagnostic imaging ; Atrial Pressure ; Retrospective Studies ; Echocardiography/methods ; Heart Failure
    Language English
    Publishing date 2023-06-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1035622-8
    ISSN 1097-6795 ; 0894-7317
    ISSN (online) 1097-6795
    ISSN 0894-7317
    DOI 10.1016/j.echo.2023.06.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Effects of pericardiocentesis on renal function and cardiac hemodynamics.

    Shmueli, Hezzy / Shah, Maulin / Patel, Yatindra / Nguyen, Long-Co / Hardy, Hannah / Rader, Florian / Siegel, Robert J

    Echocardiography (Mount Kisco, N.Y.)

    2024  Volume 41, Issue 2, Page(s) e15764

    Abstract: Background: Previous case studies have reported reversal of acute renal failure after pericardiocentesis in pericardial effusion. This study examines the effects of pericardiocentesis on preprocedural low cardiac output and acute renal dysfunction in ... ...

    Abstract Background: Previous case studies have reported reversal of acute renal failure after pericardiocentesis in pericardial effusion. This study examines the effects of pericardiocentesis on preprocedural low cardiac output and acute renal dysfunction in patients with pericardial effusion.
    Methods: This is a retrospective study of 95 patients undergoing pericardiocentesis between 2015 and 2020. Pre- and post-procedure transthoracic echocardiograms (TTE) were reviewed for evidence of cardiac tamponade, resolution of pericardial effusion, and for estimation of right atrial (RA) pressure and cardiac output. Laboratory values were compared at presentation and post-procedure. Patients on active renal replacement therapy were excluded.
    Results: Ninety-five patients were included for analysis (mean age 62.2 ± 17.8 years, 58% male). There was a significant increase in glomerular filtration rate pre- and post-procedure. Fifty-six patients (58.9%) had an improvement in glomerular filtration rate after pericardiocentesis (termed "responders"), and these patients had a lower pre-procedure glomerular filtration rate than "non-responders." There was a significant improvement in estimated cardiac output and right atrial pressure for patients in both groups. Patients who had an improvement in renal function had significantly lower pre-procedural diastolic blood pressure and mean arterial pressure.
    Conclusions: Pericardial drainage may improve effusion-mediated acute renal dysfunction by reducing right atrial pressure and thus systemic venous congestion, and by increasing forward stroke volume and perfusion pressure.
    MeSH term(s) Humans ; Male ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Female ; Pericardiocentesis ; Pericardial Effusion/diagnostic imaging ; Pericardial Effusion/surgery ; Retrospective Studies ; Cardiac Tamponade/surgery ; Hemodynamics ; Kidney Diseases ; Kidney/diagnostic imaging
    Language English
    Publishing date 2024-02-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 843645-9
    ISSN 1540-8175 ; 0742-2822
    ISSN (online) 1540-8175
    ISSN 0742-2822
    DOI 10.1111/echo.15764
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Safe to go with the flow? Large left atrial appendage thrombus despite robust appendage flow velocities.

    Yuan, Neal / Rader, Florian / Siegel, Robert J

    European heart journal. Cardiovascular Imaging

    2020  Volume 22, Issue 6, Page(s) e76

    MeSH term(s) Atrial Appendage/diagnostic imaging ; Atrial Fibrillation/diagnostic imaging ; Atrial Function, Left ; Blood Flow Velocity ; Echocardiography, Transesophageal ; Heart Diseases ; Humans ; Thrombosis/diagnostic imaging
    Language English
    Publishing date 2020-11-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 2638345-7
    ISSN 2047-2412 ; 2047-2404
    ISSN (online) 2047-2412
    ISSN 2047-2404
    DOI 10.1093/ehjci/jeaa290
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Determining Which Hospitalized Coronavirus Disease 2019 Patients Require Urgent Echocardiography.

    Yuan, Neal / Wu, Stephanie / Rader, Florian / Siegel, Robert J

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography

    2021  Volume 34, Issue 8, Page(s) 831–838

    Abstract: Background: Patients hospitalized with coronavirus disease 2019 (COVID-19) often have abnormal findings on transthoracic echocardiography (TTE). However, although not all abnormalities on TTE result in changes in clinical management, performing TTE in ... ...

    Abstract Background: Patients hospitalized with coronavirus disease 2019 (COVID-19) often have abnormal findings on transthoracic echocardiography (TTE). However, although not all abnormalities on TTE result in changes in clinical management, performing TTE in recently infected patients increases disease transmission risks. It remains unknown whether common biomarker tests, such as troponin and B-type natriuretic peptide (BNP), can help distinguish in which patients with COVID-19 TTE may be safely delayed until infection risks subside.
    Methods: Using electronic health records data and chart review, the authors retrospectively studied all patients hospitalized with COVID-19 in a multisite health care system from March 1, 2020, to January 15, 2021, who underwent TTE within 14 days of their first positive COVID-19 result and had BNP and troponin measured before or within 7 days of TTE. The primary outcome was the presence of one or more urgent echocardiographic findings, defined as left ventricular ejection fraction ≤ 35%, wall motion score index ≥ 1.5, moderate or greater right ventricular dysfunction, moderate or greater pericardial effusion, intracardiac thrombus, pulmonary artery systolic pressure > 50 mm Hg, or at least moderate to severe valvular disease. Stepwise logistic regression was conducted to determine biomarkers and comorbidities associated with the outcome. The performance of a rule for classifying TTE using troponin and BNP was evaluated.
    Results: Four hundred thirty-four hospitalized and 151 intensive care unit patients with COVID-19 were included. Urgent findings on TTE were present in 105 patients (24.2%). Troponin and BNP were abnormal in 311 (71.7%). Heart failure (odds ratio, 5.41; 95% CI, 2.61-11.68), troponin > 0.04 ng/mL (odds ratio, 4.40; 95% CI, 2.05-10.05), and BNP > 100 pg/mL (odds ratio, 5.85; 95% CI, 2.35-16.09) remained significant predictors of urgent findings on TTE after stepwise selection. No urgent findings on TTE were seen in 95.1% of all patients and in 91.3% of intensive care unit patients with normal troponin and BNP.
    Conclusions: Troponin and BNP were highly associated with urgent echocardiographic findings and may be used in triaging algorithms for determining in which patients TTE can be safely delayed until after their peak infectious window has passed.
    MeSH term(s) Aged ; COVID-19/epidemiology ; Comorbidity ; Critical Care/methods ; Echocardiography/methods ; Emergencies ; Female ; Heart Diseases/diagnosis ; Heart Diseases/epidemiology ; Heart Diseases/physiopathology ; Humans ; Inpatients ; Male ; Middle Aged ; Retrospective Studies ; SARS-CoV-2 ; Stroke Volume/physiology ; Ventricular Function, Left/physiology
    Language English
    Publishing date 2021-04-01
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Observational Study ; Research Support, N.I.H., Extramural
    ZDB-ID 1035622-8
    ISSN 1097-6795 ; 0894-7317
    ISSN (online) 1097-6795
    ISSN 0894-7317
    DOI 10.1016/j.echo.2021.03.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Oral Anticoagulant Use in Morbid Obesity and Post Bariatric Surgery: A Review.

    Nasser, Mohamed Farhan / Jabri, Ahmad / Gandhi, Sanjay / Rader, Florian

    The American journal of medicine

    2021  Volume 134, Issue 12, Page(s) 1465–1475

    Abstract: Bariatric surgery has emerged as a therapy for obesity and the associated comorbidities. Obesity has been shown to be a risk factor for atrial fibrillation as well as venous thromboembolism, both of which are conditions that warrant anticoagulation. ... ...

    Abstract Bariatric surgery has emerged as a therapy for obesity and the associated comorbidities. Obesity has been shown to be a risk factor for atrial fibrillation as well as venous thromboembolism, both of which are conditions that warrant anticoagulation. There is significant underrepresentation of the morbidly obese population in prospective trials that evaluated direct oral anticoagulants and vitamin K antagonists in atrial fibrillation and venous thromboembolism. We aim to review all the available data that assessed these oral anticoagulants in the morbidly obese population (body mass index >40 kg/m
    MeSH term(s) Anticoagulants/therapeutic use ; Atrial Fibrillation/complications ; Atrial Fibrillation/drug therapy ; Bariatric Surgery ; Factor Xa Inhibitors/therapeutic use ; Humans ; Obesity, Morbid/complications ; Obesity, Morbid/surgery ; Stroke/etiology ; Stroke/prevention & control ; Venous Thromboembolism/complications ; Venous Thromboembolism/drug therapy ; Warfarin/therapeutic use
    Chemical Substances Anticoagulants ; Factor Xa Inhibitors ; Warfarin (5Q7ZVV76EI)
    Language English
    Publishing date 2021-08-15
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80015-6
    ISSN 1555-7162 ; 1873-2178 ; 0002-9343 ; 1548-2766
    ISSN (online) 1555-7162 ; 1873-2178
    ISSN 0002-9343 ; 1548-2766
    DOI 10.1016/j.amjmed.2021.07.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top